Disagreement in risk groups for metastatic renal cancer.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
In patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a crucial part of clinical assessment and essential for guiding management. New research has now demonstrated that disagreement in risk-group classification is common and prognostically relevant.
Description
Journal Title
Nat Rev Urol
Conference Name
Journal ISSN
1759-4812
1759-4820
1759-4820
Volume Title
16
Publisher
Springer Nature
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as http://www.rioxx.net/licenses/all-rights-reserved
